Strategic planning in a regulated trade bloc: The pharmaceutical industry in the European Union

European Management Journal

Volumn 15, Issue 6, 1997, Pages 686-697

  Chaudhry, Peggy ^a   Dacin, Peter ^b  

^a VILLANOVA UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031541431     PISSN: 02632373     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0263-2373(97)00052-2     Document Type: Article

References (30)

1. Anon (1990) Proposal for a Council Regulation (EEC) Concerning the Creation of a Supplementary Protection Certificate for Medicinal Products Luxembourg: Commission of the European Communities, Office for Official Publications of the European Communities.
2. Anon (1992) Miracle Drugs or Media Drugs? Consumer Reports, March, 142-145.
3. Anon (1994) On the Outlines of an Industrial Policy for the Pharmaceutical Sector in the European Community. Luxembourg: Office for Official Publications of the European Communities.
4. Anon (1995) Association Européenne des Spécialités Pharmaceutiques Grand Public [AESGP] Conference - A Prescription for Collaboration. Lexis-Nexis database.
5. Anon (1996a) Merck Breaks the Mold. Pharmaceutical Executive, December, 28, Lexis-Nexis database.
6. Anon (1996b) Public Image - the Chemical Reaction. Society of Chemical Industry (UK), December 2, Lexis-Nexis database.
7. Anon (1997) Flynn Speech on EU Health Policy, Self-Medication. In The Reuter European Community Report, February 27, Lexis-Nexis database.
8. Bailey, R. (1990). The fourth hurdle. Forbes April 2, 166-167.
9. Burstall, M.L. (1988). The 'Cost of Non-Europe' in the Pharmaceutical Industry. Research on the 'Cost of Non-Europe': Basic Findings. Luxembourg: Commission of the European Communities, Office for Official Publications of the European Communities.
10. Cavusgil, S.T. and Sikora, E. (1988). How multinationals can counter gray market imports. Columbia Journal of World Business Winter, 75-85.
11. Chaudhry, P. and Walsh, M. (1995). Gray marketing of pharmaceuticals. Journal of Health Care Marketing 15(3), Fall, 18-22.
12. Chaudhry, P. and Walsh, M. (1995). Managing the gray market in the European Union: the case of the pharmaceutical industry. Journal of International Marketing 3(3), 11-33.
13. Chaudhry, P., Dacin, P. and Peter, J.P. (1994). The pharmaceutical industry and European Community integration. European Management Journal 12(4), December, 442-453.
14. EURECOM (1995). New York: A monthly bulletin of European Union Economic and Financial News.
15. Fielding, N. and Fielding, J. (1986). Linking Data. Sage, Newbury Park, CA.
16. Gilbert, D. and Chetley, A. (1996) New trends in drug promotion. Consumer Policy Review, September/October, 162-167.
17. Gopal, K. (1997) Wholesale wars. Pharmaceutical Executive February, 38, Lexis-Nexis database.
18. King, N. (1994). The qualitative research interview. In Qualitative Methods in Organizational Research: A Practical Guide. eds. Catherine Cassell and Gillian Symon, Sage, Thousand Oaks, CA.
19. Macarthur, D. (1989). Pricing and Reimbursement of Pharmaceuticals in the European Community -Transparency and Beyond. PJB Publications Ltd, United Kingdom.
20. Mahon, J. and Murray, E. (1981). Strategic planning for regulated companies. Strategic Management Journal 2, 251-262.
21. Marshall, C. and Rossman, G. (1989). Designing Qualitative Research. Sage, Newbury Park, CA.
22. Miles, R. and Snow, C. (1978). Organizational Strategy, Structure and Process. McGraw-Hill, New York.
23. Nugent, N. (1989). The Government and Politics of the European Community. Duke University Press, Durham, SC.
24. Porter, M. (1980). Competitive Strategy. The Free Press, New York.
25. Remit Consultants. (1991). Impediments to Parallel Trade in Pharmaceuticals Within the European Community. A report prepared for the Commission of the European Communities.
26. Scrip's 1990 Yearbook. PJB Publications, United Kingdom.
27. Smith, K, and Grimm, C. (1987). Environmental variation, strategic change and firm performance: a study of railroad deregulation. Strategic Management Journal 8, 363-376.
28. Spilker, B. (1989). Multinational Drug Companies: Issues in Drug Discovery and Development. Raven Press, New York.
29. Strauss, A. L. (1990). Qualitative Analysis for Social Scientists, Cambridge University Press, Cambridge.
30. Zeithaml, C, and Zeithaml, V. (1984). Environmental management: revising the marketing perspective. Journal of Marketing 48, 46-53.